GT Biopharma (GTBP) Non-Current Assets (2010 - 2024)
GT Biopharma's Non-Current Assets was $27,000 in Q1 2024, down 81.9% from $149,000 a year earlier and down 49.1% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Non-Current Assets (2010 - 2024) Analysis & Trends
At the end of FY2023, Non-Current Assets at GT Biopharma came in at $53,000, down 69.5% from FY2022.
- Non-Current Assets shows a five-year compound annual growth rate of -70.9% (FY2018 to FY2023).
- In earlier years, Non-Current Assets was $174,000 in FY2022 and $122,000 in FY2019 (-99.5%).
- The Q1 2024 figure marks the lowest quarterly Non-Current Assets since Q2 2017.
- Compared with a year earlier, Non-Current Assets has declined for five straight quarters, with an average decline of 57.5% over the last five quarters.
- Over the past five years, the year-over-year decline in Non-Current Assets ranged from 39.4% (Q1 2023) to 99.6% (Q2 2020).
- Per Business Quant data, GTBP's Non-Current Assets in the three quarters before Q1 2024 was $53,000 (Q4 2023), $96,000 (Q3 2023) and $123,000 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,162.99 Bn | 1,131.58 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 633.71 Bn | 552.23 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 502.40 Bn | 475.51 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 376.48 Bn | 330.86 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.02 Bn | 240.70 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 240.85 Bn | 196.25 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 193.39 Bn | 167.58 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 159.77 Bn |
| 10 | GT Biopharma | 6.59 Mn | -16.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 53,000.00 |
| Sep 30, 2023 | 96,000.00 |
| Jun 30, 2023 | 123,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 174,000.00 |
| Sep 30, 2022 | 199,000.00 |
| Jun 30, 2022 | 223,000.00 |
| Mar 31, 2022 | 246,000.00 |
| Sep 30, 2020 | 84,000.00 |
| Jun 30, 2020 | 92,000.00 |
| Mar 31, 2020 | 107,000.00 |
| Dec 31, 2019 | 122,000.00 |
| Sep 30, 2019 | 145,000.00 |
| Jun 30, 2019 | 25.42 Mn |
| Mar 31, 2019 | 25.46 Mn |
| Dec 31, 2018 | 25.31 Mn |
| Sep 30, 2018 | 25.29 Mn |
| Jun 30, 2018 | 253.92 Mn |
| Mar 31, 2018 | 254.46 Mn |
API Access
GT Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();